An enhanced IL17 and muted type I interferon nasal epithelial cell state characterizes severe COVID-19 with fungal coinfection
Microbiology Spectrum · 2024
DOI: 10.1128/spectrum.03516-23 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Carly G K Ziegler und 23 weiteren Autor:innen. Beteiligte Einrichtung: Program in Health Sciences & Technology, Harvard Medical School & MIT, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Interleukin-17, COVID-19, Coinfection, Interferon Type I. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HHS | NIH | National Institute of General Medical Sciences (NIGMS), HHS | NIH | NIAID | Division of Intramural Research (DIR, NIAID), Chan Zuckerberg Initiative (CZI).
Abstract (Originalsprache)
Recent case reports and epidemiological data suggest that fungal infections represent an underappreciated complication among people with severe COVID-19. However, the frequency of fungal colonization in patients with COVID-19 and associations with specific immune responses in the airways remain incompletely defined. We previously generated a single-cell RNA-sequencing data set characterizing the upper respiratory microenvironment during COVID-19 and mapped the relationship between disease severity and the local behavior of nasal epithelial cells and infiltrating immune cells. Our previous study, in agreement with findings from related human cohorts, demonstrated that a profound deficiency in host immunity, particularly in type I and type III interferon signaling in the upper respiratory tract, is associated with rapid progression to severe disease and worse clinical outcomes. We have now performed further analysis of this cohort and identified a subset of participants with severe COVID-19 and concurrent detection of Candida species-derived transcripts within samples collected from the nasopharynx and trachea. Here, we present the clinical characteristics of these individuals. Using matched single-cell transcriptomic profiles of these individuals’ respiratory mucosa, we identify epithelial immune signatures suggestive of IL17 stimulation and anti-fungal immunity. Further, we observe a significant expression of anti-fungal inflammatory cascades in the nasal and tracheal epithelium of all participants who went on to develop severe COVID-19, even among participants without detectable genetic material from fungal pathogens. Together, our data suggest that IL17 stimulation—in part driven by Candida colonization—and blunted interferon signaling represent a common feature of severe COVID-19 infection. IMPORTANCE In this paper, we present an analysis suggesting that symptomatic and asymptomatic fungal coinfections can impact patient disease progression during COVID-19 hospitalization. By looking into the presence of other pathogens and their effect on the host immune response during COVID-19 hospitalizations, we aim to offer insight into an underestimated scenario, furthering our current knowledge of determinants of severity that could be considered for future diagnostic and intervention strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Program in Health Sciences & Technology, Harvard Medical School & MIT, Boston, Massachusetts, USA.
- Ragon Institute of MGH, MIT, and Harvard, Cambridge, Massachusetts, USA.
- Broad Institute of MIT and Harvard, Cambridge, Massachusetts, USA.
- Harvard Graduate Program in Biophysics, Harvard University, Cambridge, Massachusetts, USA.
- Institute for Medical Engineering & Science, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA.
- Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA.
ORCID-Profile: Michelle Galeas-Pena, Michail S Lionakis, Alex K Shalek, Jose Ordovas-Montanes, Bruce H Horwitz, Sarah C Glover
Förderung
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- HHS | NIH | NIAID | Division of Intramural Research (DIR, NIAID)
- Chan Zuckerberg Initiative (CZI)
- NHLBI NIH HHS
- NIGMS NIH HHS
- NIAID NIH HHS
- NIDCR NIH HHS
- HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID)
Zitieren
APA
Ziegler, C. G. K., Owings, A. H., Galeas-Pena, M., Kazer, S. W., Miao, V. N., Navia, A. W., Tang, Y., Bromley, J. D., Lotfy, P., Sloan, M., Laird, H., Williams, H. B., George, M., Drake, R. S., Pride, Y., Abraham, G. E., Senitko, M., Robinson, T. O., Diamond, G., …, & Glover, S. C. (2024). An enhanced IL17 and muted type I interferon nasal epithelial cell state characterizes severe COVID-19 with fungal coinfection. Microbiology Spectrum. https://doi.org/10.1128/spectrum.03516-23
Vancouver
Ziegler CGK, Owings AH, Galeas-Pena M, Kazer SW, Miao VN, Navia AW, et al. An enhanced IL17 and muted type I interferon nasal epithelial cell state characterizes severe COVID-19 with fungal coinfection. Microbiology Spectrum. 2024. doi:10.1128/spectrum.03516-23
BibTeX
@article{Ziegler2024,
author = {Ziegler, Carly G K and Owings, Anna H and Galeas-Pena, Michelle and Kazer, Samuel W and Miao, Vincent N and Navia, Andrew W and Tang, Ying and Bromley, Joshua D and Lotfy, Peter and Sloan, Meredith and Laird, Hannah and Williams, Haley B and George, Micayla and Drake, Riley S and Pride, Yilianys and Abraham, George E and Senitko, Michal and Robinson, Tanya O and Diamond, Gill and Lionakis, Michail S and Shalek, Alex K and Ordovas-Montanes, Jose and Horwitz, Bruce H and Glover, Sarah C},
title = {An enhanced IL17 and muted type I interferon nasal epithelial cell state characterizes severe COVID-19 with fungal coinfection},
journal = {Microbiology Spectrum},
year = {2024},
doi = {10.1128/spectrum.03516-23}
}
EUVIMED